RecruitingNCT06746155

Predictors of Relapse in Major Depressive Disorder (PERFORM-D)

Predictors of Early Relapse During Follow-up Of Remitted Major Depression


Sponsor

Abraham Nunes

Enrollment

252 participants

Start Date

Dec 27, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Major depressive disorder (MDD) is a common condition involving recurring periods of depression. One of the major challenges faced by people with MDD is that the episodes of depression tend to recur even after they are successfully treated. Currently, it is hard to predict when a depressive episode will recur. Being able to forecast this would help healthcare providers monitor patients and prevent relapse. The purpose of this study is to monitor features such as clinical symptoms, physical activity, sleep patterns, cognitive functioning and brain activity to help us understand how relapse happens and the mechanisms that cause it. From these different types of data, investigators will build a model that tells us who is more likely to experience a relapse and when the relapse is likely to occur. This study will be a significant step forward in understanding and managing MDD. Investigator will create a practical tool that will allow healthcare providers to monitor patients more effectively. By identifying early signs of relapse, investigators may be able to intervene promptly to prevent depressive episodes. Finally, our research will help understand the factors that underlie relapse in MDD, which will encourage the development of novel treatment approaches.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study aims to identify warning signs (in sleep patterns, mood, and other factors tracked by a wrist device and self-reports) that may predict when someone with major depressive disorder (MDD) is at risk of relapsing, even during a period of remission or response to treatment. **You may be eligible if...** - You are between 18 and 70 years old - You have been diagnosed with major depressive disorder (MDD) - Your current depressive symptoms are mild (MADRS score ≤ 14, meaning you are in remission or responding to treatment) - You are willing to wear a wrist activity tracker throughout the study - You have sufficient English fluency to complete self-report questionnaires **You may NOT be eligible if...** - You have a lifetime diagnosis of bipolar disorder, schizophrenia, or schizoaffective disorder - You have an elevated risk of suicide - You have a major neurological disorder or significant head injury - You have any condition that would interfere with the study assessments Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(8)

University of Calgary

Calgary, Alberta, Canada

University of British Columbia

Vancouver, British Columbia, Canada

Nova Scotia Health

Halifax, Nova Scotia, Canada

McMaster University

Hamilton, Ontario, Canada

Queen's University

Kingston, Ontario, Canada

Centre for Addiction and Mental Health (CAMH)

Toronto, Ontario, Canada

University Health Network

Toronto, Ontario, Canada

Ontario Shores Centre for Mental Health Sciences

Whitby, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06746155


Related Trials